Skip to main content
. 2019 Sep 18;10:1043. doi: 10.3389/fphar.2019.01043

Figure 3.

Figure 3

Transfection of cancer cells by RL2:pEGFP at charge ratios from 5 to 9. (A) Cells were incubated with LF—Lipofectamine 3000 and pEGFP, free pEGFP or RL2-pEGFP complexes with various N/P ratios and 24 h after EGFP was analyzed by fluorescent microscopy. (B) Cells were pre-treated with anti-RL2 antibodies (ab) for 3 h and next transected with a complex RL2:pEGFP. (C) Electrophoretic analysis of the products of RT-PCR reaction with EGFP-specific primers. Free pUC19 and pEGFP were used as matrixes in PCR reaction for the negative and positive controls, respectively. Representative pictures of three independent experiments.